Transaction · 0001493152-26-040513

Svf Pauling (Cayman) Ltd

SVF Pauling (Cayman) Ltd, 10%, reported an open-market or private sale at Relay Therapeutics, Inc. involving 6000000.000000 shares for an estimated $116400000.00. Reported holdings after the transaction were 21904963.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code S10%
RLAYRelay Therapeutics, Inc.
Estimated value-$116MShares × reported price
Shares traded6.00M$19.40 per share
Holdings after21.9MIndirect · See footnote
% of reported position traded21.5%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 27,904,963 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

RLAY price since this filing

Daily closing prices, with the filing date and available return windows
RLAY · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -1.8%1w ago +9.8%1d ago +5.3%
Returns since7d +1.4%30d -6.9%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001493152-26-040513
Common Stock
Transaction date
Aug 25, 2026
Filed Aug 28, 2026, 01:01 PM · 3d delay
Shares
6,000,000 sh
$19.40 per share
Estimated value
-$116M
Computed from shares × price
Holdings after
21,904,963 sh
Indirect · See footnote

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Large Holdings Reduction Large Sale
Filing-only score

0 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
    Read the scoring methodology

    Signed filing-only points, not a probability or expected return. Version v1.

    Reported relationships & other filings

    Form 4 relationship flags and nearby filing context

    Reported roles

    No officer title

    Officer NoDirector No10% YesOther No
    Footnotes & amended
    1. F1

      Securities held of record by SVF Pauling (Cayman) Limited, a wholly owned subsidiary of SoftBank Vision Fund (AIV M2) L.P. ("AIV M2"). SB Investment Advisers (UK) Limited ("SBIA UK") has been appointe…

    Original filing · 0001493152-26-040513
    Related transactions

    0 other transactions

    Same SEC filing
    Recent company activity

    0 recent txs

    RLAY